ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $829M invested in Intra-Cellular Therapies Inc. in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 47
Holders
131
Holding in Top 10
–
Calls
$30.8M
Puts
$21M
Top Buyers
| 1 | +$39.3M | |
| 2 | +$23.6M | |
| 3 | +$20.5M | |
| 4 |
DFO
Duquesne Family Office
New York
|
+$6.25M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.15M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$8.82M | |
| 3 | -$7.38M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$6.14M |
| 5 |
BlackRock
New York
|
-$5.26M |